City
Epaper

'Vax drive for teens strengthened India's fight against Covid'

By IANS | Updated: January 13, 2022 21:05 IST

New Delhi, Jan 13 The ongoing vaccination drive for teenagers in the 15-18 age bracket has further strengthened ...

Open in App

New Delhi, Jan 13 The ongoing vaccination drive for teenagers in the 15-18 age bracket has further strengthened India's fight against the Covid-19 pandemic, N.K. Arora, Chairman of the Covid-19 Working Group of National Technical Advisory Group on Immunisation (NTAGI), told on Thursday.

"Vaccinating teenagers will give parents the confidence to send them to school and help them resume normal activities while maintaining Covid appropriate behaviour," Arora said.

Since the beginning of the vaccination drive for the 15 to 18 age group on January 3, over three crore teens have been vaccinated with the first dose so far. As per an estimation, there are around 7.50 crore teens in this age bracket in India to whom vaccine shots will be administered.

Talking about Ahmedabad-based Zydus Cadilla's ZyCovD vaccine, the world's first plasmid-DNA vaccine approved for those above 12 years, Arora said, "Since it is the first DNA vaccine, the government wants to be doubly sure of its safety before providing it to children. So, its first one crore doses will be given to adults."

"The vaccine was found to be absolutely safe and highly efficacious during the trials. We are sure that it will soon be available for children as well," he said.

"Data shows that children are as susceptible to catching the infection as adults are. The vaccine protects against severe disease. The older teenagers are quite socially active and so they are at a higher risk of catching the virus as compared to younger kids.

"

On vaccine's side-effects among teens, Manju Puri, consultant gynaecologist at Lady Hardinge Medical College, said that it is a time-tested technology which is both safe and efficacious.

No major side-effects have been reported yet, she said, adding that children, like adults, may experience mild side-effects such as pain at the vaccine site, fatigue, or mild fever for a few days.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: New DelhiindiaCovid-19 working group of national technical advisory group on immunisationNtagiManju puri
Open in App

Related Stories

MaharashtraOver 10,000 Pakistani Nationals Traced in Maharashtra and Delhi Post-Palgham Terror Attack

MumbaiViral Sighting of Tesla Cybertruck Near Mumbai Stirs EV Enthusiasm (Photos)

NationalPM Narendra Modi Discusses Tech and Innovation Collaboration With Elon Musk

NationalTahawwur Rana Extradition: Pakistan Distances Itself From 26/11 Accused After Arrival in India

NationalIndia Expands Rafale Power: Rs 64,000 Crore Deal Cleared for Navy Fighter Jets

Health Realted Stories

HealthPiyush Goyal lashes out at Big Pharma for evergreening patents

HealthHealthcare for India means wellness and happiness, not just treatment: Piyush Goyal

HealthTo make health accessible, we must make it affordable: Mansukh Mandaviya

HealthTelangana’s first intestine transplant performed at Osmania Hospital

HealthHimachal takes steps to retain specialist doctors